Advanced Life Sciences Holdings Inc. (ADLS) and Wyeth (WYE) Collaborate to Address Global Concern over Community Acquired Pneumonia
Community-acquired pneumonia (CAP) occurs when individuals who have not been recently hospitalized develop a pneumonia infection. This disease is the sixth most common cause of death in the United States, affecting people of all ages. If not properly treated, CAP can be fatal. Researchers are finding it harder to treat CAP as it grows more resistant to current antibiotics, leaving drug company researchers scrambling to develop an efficient treatment. Last week, Advanced Life Sciences Holdings Inc. (Nasdaq: ADLS) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced they have signed a development and commercialization agreement for an oral antibiotic…